Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

计划入组 75 人 · 首次发布于 2012 年 3 月 14 日

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

计划入组 9 人 · 首次发布于 2015 年 1 月 21 日

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

计划入组 48 人 · 首次发布于 2019 年 8 月 22 日

Temozolomide(Temodar, Temomedac, Temodal, Temozolomide Sun, Temozolomide Accord, Temozolomide Teva, Kizfizo)

C₆H₆N₆O₂ · Rx

Mirdametinib Achieves 87% Response Rate in Pediatric Low-Grade Glioma Phase 1/2 Trial

UK Government Launches Major Initiative to Improve Brain Tumour Clinical Trial Access Through NHS App Integration

Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients